Matthias Briel

Status: Abgeschlossen Dauer: Jan. 2009 - Okt. 2016

We will conduct and update several systematic reviews and meta-analyses investigating the benefit and adverse events of fibrates, ezetimibe, and niacin in primary and secondary prevention of cardiovascular disease.